Ethical Considerations in the Implantation of Neuromodulatory Devices.

OBJECTIVES Neuromodulatory devices are increasingly used by neurosurgeons to manage a variety of chronic conditions. Given their potential benefits, it is imperative to create clear ethical guidelines for the use of these devices. We present a tiered ethical framework for neurosurgeon recommendations for the use of neuromodulatory devices. MATERIALS AND METHODS We conducted a literature review to identify factors neurosurgeons should consider when choosing to offer a neuromodulatory device to a patient. RESULTS Neurosurgeons must weigh reductions in debilitating symptoms, improved functionality, and preserved quality of life against risks for intraoperative complications and adverse events due to stimulation or the device itself. Neurosurgeons must also evaluate whether patients and families will maintain responsibility for the management of neuromodulatory devices. Consideration of these factors should occur on an axis of resource allocation, ranging from provision of neuromodulatory devices to those with greatest potential benefit in resource-limited settings to provision of neuromodulatory devices to all patients with indications in contexts without resource limitations. Neurosurgeons must also take action to promote device effectiveness throughout the duration of care. CONCLUSIONS Weighing risks and benefits of providing neuromodulatory devices and assessing ability to remain responsible for the devices on the level of the individual patient indicate which patients are most likely to achieve benefit from these devices. Consideration of these factors on an axis of resource allocation will allow for optimal provision of neuromodulatory devices to patients in settings of varied resources. Neurosurgeons play a primary role in promoting the effectiveness of these devices.

[1]  S. Lam,et al.  Informed consent in neurosurgery: a systematic review. , 2020, Neurosurgical focus.

[2]  R. D'souza,et al.  Neuromodulation With Burst and Tonic Stimulation Decreases Opioid Consumption: A Post Hoc Analysis of the Success Using Neuromodulation With BURST (SUNBURST) Randomized Controlled Trial , 2020, Neuromodulation : journal of the International Neuromodulation Society.

[3]  Michelle E. Waldron,et al.  DBS-Edmonton App, a Tool to Manage Patient Expectations of DBS in Parkinson Disease , 2020, Neurology. Clinical practice.

[4]  P. House,et al.  Use of the mixed reality tool “VSI Patient Education” for more comprehensible and imaginable patient educations before epilepsy surgery and stereotactic implantation of DBS or stereo-EEG electrodes , 2019, Epilepsy Research.

[5]  Kyle T. Mitchell,et al.  Patient Experience with Rechargeable Implantable Pulse Generator Deep Brain Stimulation for Movement Disorders , 2019, Stereotactic and Functional Neurosurgery.

[6]  T. Aziz,et al.  Study Protocol: Using Deep-Brain Stimulation, Multimodal Neuroimaging and Neuroethics to Understand and Treat Severe Enduring Anorexia Nervosa , 2018, Front. Psychiatry.

[7]  Michael C. Park,et al.  Bridging the Gaps in Patient Education for DBS Surgery in Parkinson's Disease , 2017, Parkinson's disease.

[8]  S. Müller,et al.  Rivaling paradigms in psychiatric neurosurgery: adjustability versus quick fix versus minimal-invasiveness , 2015, Front. Integr. Neurosci..

[9]  H. Mayberg Dualism in the Era of Device Interventions: Recovery Takes More Than a Stimulator , 2014 .

[10]  C. Kubu,et al.  Beyond Mere Symptom Relief in Deep Brain Stimulation: An Ethical Obligation for Multifaceted Assessment of Outcome , 2012, AJOB neuroscience.

[11]  E. Racine,et al.  Ethics guidance for neurological and psychiatric deep brain stimulation. , 2013, Handbook of clinical neurology.

[12]  C. Woopen Ethical aspects of neuromodulation. , 2012, International review of neurobiology.

[13]  Elliot S. Krames,et al.  What Is Neuromodulation , 2009 .